Skip to content

COBAS INTEGRA Creatinine Jaffe for use on the INTEGRA 400… recallZ-0667-03 · Roche Diagnostics Corp. · initiated Feb 13, 2003

Terminated All recalls posted in March 2003

Is my device affected?

  1. Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
  2. If yours is listed, follow the instructions from Roche Diagnostics Corp. or your healthcare provider. The company's action is summarized under what the company is doing.
  3. Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.

Where to find your model and lot numbers · What recall classes and statuses mean

Why it was recalled

After a cassette change, patient results and controls may be up to 40% too low or too high due to calibration factor variation.

FDA root cause category: Other

What the company is doing

An urgent product removal bulletin dated 2/14/03 was sent to each affected customer advising them to discontinue use of this lot, to discard any product on hand, and to contact Roche for replacement.

Recall details

Recall number
Z-0667-03
Recall class
Not yet classified by the FDA
Status
Terminated
Initiated by the company
Feb 13, 2003
Posted by the FDA
Mar 21, 2003
Recalling firm
Roche Diagnostics Corp.
Quantity
1905
FDA submissions
K951595
Distribution
United States

Product description

COBAS INTEGRA Creatinine Jaffe for use on the INTEGRA 400, 700 and 800 analyzers; system ID # 0764345, catalog # 20764345

Code information (models, lots, serial numbers)

lot 639106

Other devices under the same FDA submission

11 devices cleared under K951595 — the recall does not name any of them by identifier. One submission often covers many models, so they may or may not be affected.

Sources and updates

How recalls are matched to devices · Editorial policy · Report an error on this page